Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-11-02 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,605 31,250
2020-11-02 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 59,896
2020-11-02 BENZENO SHARON Chief Business Development Off Option exercise · Common Stock (Right to Buy) −1,563 40,625
2020-10-26 Taylor Stacy L SVP and General Counsel Option exercise +1,110 $7.80 $9K 2,410
2020-10-26 Taylor Stacy L SVP and General Counsel Option exercise +1,770 $6.55 $12K 4,180
2020-10-26 Taylor Stacy L SVP and General Counsel Sale −618 $49.11 $30K 3,562
2020-10-26 Taylor Stacy L SVP and General Counsel Sale −2,262 $49.96 $113K 1,300
2020-10-26 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,110 35,035
2020-10-26 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,770 30,105
2020-10-19 BENZENO SHARON Chief Business Development Off Option exercise +417 $6.27 $3K 417
2020-10-19 BENZENO SHARON Chief Business Development Off Sale −417 $51.25 $21K 0
2020-10-19 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −417 2,500
2020-10-16 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-10-16 ROBINS HARLAN S Chief Scientific Officer Sale −11,100 $51.79 $575K 679
2020-10-16 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 267,000
2020-10-15 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-10-15 ROBINS HARLAN S Chief Scientific Officer Sale −11,100 $51.55 $572K 679
2020-10-15 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 278,100
2020-10-15 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2020-10-15 HERSHBERG ROBERT Director Sale −2,000 $51.51 $103K 0

Page 85 of 120 · 2,386 trades